Proteomics-based investigation of cerebrovascular molecular mechanisms in cerebral amyloid angiopathy by the FFPE-LMD-PCT-SWATH method
Abstract Background Cerebral amyloid angiopathy (CAA) occurs in 80% of patients with Alzheimer’s disease (AD) and is mainly caused by the abnormal deposition of Aβ in the walls of cerebral blood vessels. Cerebrovascular molecular mechanisms in CAA were investigated by using comprehensive and accurat...
Main Authors: | Takumi Handa, Hayate Sasaki, Masaki Takao, Mitsutoshi Tano, Yasuo Uchida |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-07-01
|
Series: | Fluids and Barriers of the CNS |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12987-022-00351-x |
Similar Items
-
Editorial: Cerebral amyloid angiopathy: from bench to bedside
by: Hamid R. Sohrabi, et al.
Published: (2024-02-01) -
Cerebral amyloid angiopathy related inflammation: An under recognized but treatable complication of cerebral amyloid angiopathy
by: Alexander Berry-Noronha, MBBS, et al.
Published: (2023-07-01) -
Rare forms of cerebral amyloid angiopathy: pathogenesis, biological and clinical features of CAA-ri and iCAA
by: Benedetta Storti, et al.
Published: (2023-07-01) -
The Role of Basement Membranes in Cerebral Amyloid Angiopathy
by: Matthew D. Howe, et al.
Published: (2020-11-01) -
Frequency of deep-seated cerebral microbleeds in patients with lobar hemorrhages and histopathological evidence for cerebral amyloid angiopathy
by: Monika Huhndorf, et al.
Published: (2023-04-01)